Abstract
I will never forget, for many reasons, the moment I first met Milan Hašek. It was in 1972 when I attended (as an undergraduate student) a scientific meeting held at the “Dejvice” branch of the Institute of Experimental Biology and Genetics of the Czechoslovak Academy of Sciences in Prague (now the Institute of Molecular Genetics), the institute Milan Hašek founded. In one of the men’s rooms of the Institute I met a tall man whom I thought I had never seen before. Nevertheless, he started to tell me a joke - talking to me as if to someone he had known for years : “There were two university students, one from Oxford and the second one from Cambridge, having done what we are doing now. The Oxford student says:’ We are taught in Oxford that after p***ing we should wash our hands.’ The second student replies, ‘Most interesting, but we are taught in Cambridge how not to p*** on our hands!’” At that time I did not have the slightest idea who the man was and how decisive my encounters with him would be.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Asherson GL, Colizzi V, Malkovský M, Colonna-Romano G, Zembala M (1985) The role of interleukin-2 as one of the determinants of the balance between immunity and unresponsiveness. Folia Biol (Praha) 31: 387–395
Colizzi V (1984) In vivo and in vitro administration of interleukin 2 containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice. Infect Immun 45: 25–28
Colizzi V, Malkovský M, Lang G, Asherson GL (1985) In vivo activity of interleukin-2: conversion of a stimulus causing unresponsiveness to a stimulus causing contact hypersensitivity by the injection of interleukin-2. Immunology 56: 653–658
Dalgleish AG, Malkovský M (1988) Advances in human retroviruses. Adv Cancer Res 51: 307–360
Dalgleish AG, Kennedy RC, Sattentau Q, Chanh T, Beverley P, Maddon P, Axel R, Malkovský M (1988) The T4 molecule: its possible use in therapeutic strategies against AIDS. In: Bolognesi D (ed) Human retroviruses, cancer and AIDS: approaches to prevention and therapy. UCLA Symposia on molecular and cellular biology. Liss, New York, pp 283–288
de Boer RJ, Hogeweg P (1987) Immunological; discrimination between self and non-self by precursor depletion and memory accumulation. J Theor Biol 124: 343–369
Diamantstein T, Osawa H (1986) The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies. Immunol Rev 92: 5–27
Essery G, Feldmann M, Lamb JR (1988) Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 64: 413–417
Holán V (1987) Successful induction of specific hyporeactivity to rat skin xenografts in newborn mice. Effect of immunoregulatory molecules. Transplantation 44: 809–812
Holán V (1989) Modulation of allotransplantation tolerance induction by interleukin-1 and interleukin-2. J Immunogenet 15: 331–338
Irschick E, Niederwieser D, Spielberger M, Schönitzer D, Lochs A, Margreiter R, Huber C (1986) Acquired donor-specific CML unresponsiveness under cyclosporine treatment is reversible by exogenous IL-2. Transplant Proc 18: 1316–1318
Jenkins MK, Schwartz RH (1987) Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165: 302–319
Kawamura H, Rosenberg SA, Berzofsky JA (1985) Immunization with antigen and interleukin-2 in vivo overcomes Ir gene low responsiveness. J Exp Med 162: 381–386
Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB (1985) Administration of anti-interleukin-2 receptor antibody prolongs cardiac allograft survival in mice. J Exp Med 162: 358–362
Kupiec-Weglinski JW, Diamantstein T, Tilney NL, Strom TB (1986) Therapy with monoclonal antibody to interleukin-2 receptor spares T suppressor cells and prevents or reverses acute allograft rejection in rats. Proc Nati Acad Sci USA 83: 2624–2627
Landolfo S, Ganglio M, Gribaudo G, Jemma C, Giovarelli M, Cavallo G (1988) Interferon-/is not an antiviral, but a growth-promoting factor for T lymphocytes. Eur J Immunol 18: 503–509
Lehtonen L, Vainio O, Toivanen P (1986) Mechanisms of transplantation tolerance in B-cell-chi-meric chickens: impairment of tolerance by T cell growth factor. Transplantation 42:184–191
Loveland B, Hunt R, Malkovský M (1986) Autologous lymphoid cells exposed to recombinant interleukin-2 in vitro in the absence of antigen can induce the rejection of long-term tolerated skin allografts. Immunology 59:159–161
Malkovský M (1987) Is T cell help involved in establishment of tolerance? Theory and experiment. In: Matzinger P, Flajnik M, Nemazee D, Rammensee HG, Rolink T, Stockinger G, Nicklin L (eds) Tolerance workshop 1986, Editiones Roche, Basle pp 73–79
Malkovský M, (1989) The relativity of immunological information. In: Aiuti F, Bonomo L, Daniei G (eds) Topics in immunology, II Pensiero Scientifico, Roma, pp 1–7
Malkovský M, Medawar PB (1984) Is immunological tolerance (non-responsiveness) a consequence of interleukin-2 deficit during the recognition of antigen? Immunol Today 5: 340–343
Malkovský M, Sondel PM (1987) Interleukin-2 and its receptor: structure, function and therapeutic potential. Blood Rev 1: 254–266
Malkovský M, Asherson GL, Stockinger B, Watkins MC (1982) Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature 300: 652–655
Malkovský M, Doré C, Hunt R, Palmer L, Chandler P, Medawar PB (1983) Enhancement of specific antitumour immunity in mice fed a diet enriched in vitamin A acetate. Proc Natl Acad Sci USA 80: 6322–6326
Malkovský M, Medawar P, Hunt R, Palmer L, Doré C (1984) A diet enriched in vitamin A acetate or in vivo administration of interleukin-2 can counteract a tolerogenic stimulus. Proc R Soc Lond [Biol] 220: 439–445
Malkovský M, Medawar PB, Thatcher DR, Toy J, Hunt R, Rayfield LS, Doré C (1985) Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin-2 or vitamin A acetate. Proc Nati Acad Sci USA 82: 536–538
Malkovský M, Brenner MK, Hunt R, Rastan S, Doré C, North ME, Aherson GL, Prentice HG, Medawar PB (1986) T-cell depletion of allogenic bone marrow prevents acceleration of graftversus-host disease induced by exogenous interleukin-2. Cell Immunol 103: 476–480
Malkovský M, Loveland B, North M, Asherson GL, Gao L, Ward P, Fiers W (1987) Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 325: 262–265
Malkovský M, Philpott K, Dalgleish AG, Mellor AL, Patterson S, Webster ADB, Edwards AJ, Maddon PJ (1988) Infection of B lymphocytes by the human immunodeficiency virus and their susceptibility to cytotoxic cells. Eur J Immunol 18:1315–1321
Pestka S, Langer JA, Zoon KC, Samuel CE (1987) Interferons and their actions. Annu Rev Biochem 56: 727–777
Tomonari K (1988) Downregulation of the T-cell receptor by a mitogenic anti-Thy-1 antibody. Eur J Immunol 18: 179–182
van Noesel C, Miedema F, Brouwer M, de Rie MA, Aarden LA, van Lier RAW (1988) Regulatory properties of LFA-1 α and β chains in human T-lymphocyte activation. Nature 333: 850–852
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Malkovský, M. (1989). Milan Hašek, Lymphokines and Retroviruses. In: Ivanyi, P. (eds) Realm of Tolerance. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74712-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-74712-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74714-4
Online ISBN: 978-3-642-74712-0
eBook Packages: Springer Book Archive